Annaida Technologies has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance.
Annaida Technologies's investors include Zürcher Kantonal Bank, Venture Kick, MassChallenge, Privilège Ventures, Club degli Investitori.
Annaida Technologies is headquartered in Lausanne, Switzerland.
Annaida Technologies has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance.
Annaida Technologies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Annaida Technologies — Funding & Investors." VCBacked, April 29, 2025, https://www.vcbacked.co/company/annaida-technologies. Accessed October 28, 2026.
VCBacked. (2025). Annaida Technologies — Funding & Investors. Retrieved October 28, 2026, from https://www.vcbacked.co/company/annaida-technologies
{{cite web |title=Annaida Technologies — Funding & Investors |url=https://www.vcbacked.co/company/annaida-technologies |website=VCBacked |access-date=October 28, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated